19
Astellas Pharma, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TACROLIMUS, with a corresponding application number 210115.
Regulatory Information RX
With a dosage strength EQ 0.2MG BASE/PACKET
Dosage Form Route FOR SUSPENSION; ORAL
Reference Listed Drug Yes
Approved since 2018-05-24
18
Astellas Pharma, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TACROLIMUS, with a corresponding application number 210115.
Regulatory Information RX
With a dosage strength EQ 1MG BASE/PACKET
Dosage Form Route FOR SUSPENSION; ORAL
Reference Listed Drug Yes
Approved since 2018-05-24